Expression signatures of cisplatin- and trametinib-treated early-stage medaka melanomas

Authors

Barbara Klotz, University of Wuerzburg
Susanne Kneitz, University of Wuerzburg
Yuan Lu, Texas State University
William Boswell, Texas State University
John Postlethwait, University of Oregon
Wesley Warren, Washington University School of Medicine in St. Louis
Ronald B. Walter, Texas State University
Manfred Shartl, University of Wuerzburg

Journal

G3: Genes, Genomes, Genetics

Publication Date

2019

Volume

9

Issue

7

First Page

2267

Last Page

2276

Document Type

Open Access Publication

DOI

10.1534/g3.119.400051

Rights and Permissions

Klotz B, Kneitz S, Lu Y, Boswell W, Postlethwait J, Warren W, Walter RB, Schartl M. Expression Signatures of Cisplatin- and Trametinib-Treated Early-Stage Medaka Melanomas. G3 (Bethesda). 2019 Jul 9;9(7):2267-2276. doi: 10.1534/g3.119.400051. Copyright © 2019 Klotz et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Recommended Citation

Klotz, Barbara; Kneitz, Susanne; Lu, Yuan; Boswell, William; Postlethwait, John; Warren, Wesley; Walter, Ronald B.; and Shartl, Manfred, "Expression signatures of cisplatin- and trametinib-treated early-stage medaka melanomas." G3: Genes, Genomes, Genetics. 9, 7. 2267 - 2276. (2019).
https://digitalcommons.wustl.edu/open_access_pubs/8038